Country: United States
Language: English
Source: NLM (National Library of Medicine)
TIAGABINE HYDROCHLORIDE (UNII: DQH6T6D8OY) (TIAGABINE - UNII:Z80I64HMNP)
Sun Pharmaceutical Industries, Inc.
TIAGABINE HYDROCHLORIDE
TIAGABINE HYDROCHLORIDE 2 mg
ORAL
PRESCRIPTION DRUG
Tiagabine hydrochloride tablets are indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. Tiagabine hydrochloride tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. The abuse and dependence potential of tiagabine hydrochloride have not been evaluated in human studies.
Tiagabine hydrochloride tablets are available in two dosage strengths. 2 mg orange, circular, film-coated tablets debossed with “200” on one side and plain on the other side, are available in: Bottles of 30: Child Resistant Cap NDC 62756-200-83 Bottles of 1000: Non Child Resistant Cap NDC 62756-200-18 4 mg yellow, circular, film-coated tablets debossed with “224” on one side and plain on the other side, are available in: Bottles of 30: Child Resistant Cap NDC 62756-224-83 Bottles of 100: Child Resistant Cap NDC 62756-224-88 Non Child Resistant Cap NDC 62756-224-08 Bottles of 1000: Non Child Resistant Cap NDC 62756-224-18 Recommended Storage: Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature]. Protect from light and moisture.
Abbreviated New Drug Application
TIAGABINE HYDROCHLORIDE - TIAGABINE HYDROCHLORIDE TABLET, FILM COATED Sun Pharmaceutical Industries, Inc. ---------- MEDICATION GUIDE Tiagabine Hydrochloride(tye-AG-a-been hye-droe-KLOR-ide)Tablets Read this Medication Guide before you start taking tiagabine hydrochloride tablets and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment. What is the most important information I should know about tiagabine hydrochloride tablets? Do not stop taking tiagabine hydrochloride tablets without first talking to your healthcare provider. Stopping tiagabine hydrochloride tablets suddenly can cause serious problems. Tiagabine hydrochloride tablets can cause serious side effects, including: 1. Tiagabine hydrochloride tablets may cause seizures in people who do not have epilepsy. If you do not have a seizure disorder and you take tiagabine hydrochloride tablets, you may have a seizure or seizures that do not stop (status epilepticus). Call your healthcare provider right away if you have a seizure and you are not taking tiagabine hydrochloride tablets for epilepsy. 2. Like other antiepileptic drugs, tiagabine hydrochloride tablets may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you: • thoughts about suicide or dying • new or worse irritability • attempts to commit suicide • acting aggressive, being angry, or violent • new or worse depression • acting on dangerous impulses • new or worse anxiety • an extreme increase in activity and panic attacks • feeling agitated or restless talking (mania) • trouble sleeping (insomnia) • other unusual changes in behavior or mood Suicidal thoughts or actions can be caused by things other than medicines. If you have suicidal thoughts or actions, your healthcare provider may check for other caus Read the complete document
TIAGABINE HYDROCHLORIDE - TIAGABINE HYDROCHLORIDE TABLET, FILM COATED SUN PHARMACEUTICAL INDUSTRIES, INC. ---------- TIAGABINE HYDROCHLORIDE TABLETS DESCRIPTION Tiagabine hydrochloride, USP is an antiepilepsy drug available as 2 mg and 4 mg tablets for oral administration. Its chemical name is (-)-(R)-1-[4,4-Bis(3- methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride, its molecular formula is C H NO S HCl, and its molecular weight is 412. Tiagabine hydrochloride is a white to off-white, odorless, crystalline powder. It is insoluble in heptane, sparingly soluble in water, and soluble in aqueous base. The structural formula is: INACTIVE INGREDIENTS Tiagabine hydrochloride tablets contain the following inactive ingredients: Hydrogenated vegetable oil, anhydrous lactose, butylated hydroxyanisole, pregelatinized maize starch, colloidal silicon dioxide, talc, crospovidone, titanium dioxide, hypromellose, polyethylene glycol. In addition, individual tablets contain: 2 mg tablets: FD&C Yellow No. 6 and polysorbate 80. 4 mg tablets: Lactose monohydrate and D&C Yellow No. 10. CLINICAL PHARMACOLOGY MECHANISM OF ACTION The precise mechanism by which tiagabine exerts its antiseizure effect is unknown, although it is believed to be related to its ability, documented in _in vitro_ experiments, to enhance the activity of gamma aminobutyric acid (GABA), the major inhibitory neurotransmitter in the central nervous system. These experiments have shown that tiagabine binds to recognition sites associated with the GABA uptake carrier. It is thought that, by this action, tiagabine blocks GABA uptake into presynaptic neurons, permitting more GABA to be available for receptor binding on the surfaces of post-synaptic cells. Inhibition of GABA uptake has been shown for synaptosomes, neuronal cell cultures, and glial cell cultures. In rat-derived hippocampal slices, tiagabine has been shown to prolong GABA-mediated inhibitory post-synaptic potentials. Tiagabine increases the amount of GABA available in the extracellular space of the gl Read the complete document